Blue Water Vaccines, Inc. (BWV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
201 East Fifth Street
Cincinnati, OH 45202
United States of America (the)
Phone
513 620 4101
Sector
Healthcare
Industry
Biotechnology
Employees
12
First IPO Date
February 18, 2022
| Name | Title | Pay | Year Born |
| Neil J. Campbell | President, Chief Executive Officer & Director | 0 | 1960 |
| James R. Sapirstein | Interim Executive Chairman | 65,625 | 1961 |
| Erin Henderson | Chief Business Officer & Corporate Secretary | 526,905 | 1975 |
| Bruce Harmon | Chief Financial Officer | 543,750 | 1958 |
| Frank A. Jaeger | Senior Vice President of Marketing & Business Development | 0 | 1971 |
| Theodore Scott Yoho | Head of Business Development | 0 | N/A |
Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria. Founded in 2018, BWV's operations are based in Cincinnati, Ohio.